TABLE 2.
Clinicopathological features of uterine leiomyosarcoma with heterogenous differentiation.
| Case | Age | Treatment | Heterologous component | Metastasis/recurrence | Interval before metastasis/recurrence | Prognosis |
|---|---|---|---|---|---|---|
| 1 | 42 | S+RA | Chondrosarcoma | Right rectus muscle | 3 years | NA |
| 2 | 45 | S | Liposarcoma | Spinal column | 6 months | NA |
| 3 | 53 | S | Osteosarcoma | NA | NA | AWD |
| 4 | 54 | S+RA | Liposarcoma, osteosarcoma, chondrosarcoma | Mesentery | 8 months | NA |
| 5 | 50 | S | Liposarcoma | Lung, Pelvic cavity | 5 months | AWD |
| 6 | 55 | S+CT | Liposarcoma | Pelvic cavity | 1 year | NA |
| 7 | 80 | RA+CT | Osteosarcoma, chondrosarcoma, liposarcoma-like area | Lung | 11 months | |
| 8 | 67 | SH | Rhabdomyosarcoma | Femur, abductor magnus, lymph node | 9 years | AWD |
| 9 | 41 | M+CT | Osteosarcoma | Lung | NA | DOD |
| 10 | 63 | S+CT | Osteosarcoma | Lung, diaphragm, atrium, SVC, kidney | NA | DOD |
| 11 | 40 | S+CT | Osteosarcoma | Colon, retroperitoneum | NA | DOD |
| 12 | 48 | S+CT+RA | Osteosarcoma | Lung, liver, peritoneum, colon, small bowel | NA | DOD |
| 13 | 55 | CT | Osteosarcoma | Pancreas, bone, lung | NA | DOD |
| 14 | 52 | S+CT | Osteosarcoma | Lung, abdomen | NA | AWD |
| 15 | 61 | S+CT+RA | Osteosarcoma | Lung, pleura | NA | DOD |
| 16 | 53 | S | Osteosarcoma | — | — | DOD |
| 17 | 62 | NA | Osteosarcoma | NA | NA | NA |
| 18 | 43 | S+CT | Osteosarcoma | Small bowel | NA | AWD |
| 19 | 52 | S+CT | Osteosarcoma | Liver, small bowel | NA | AWD |
Abbreviations: S, surgery; RA, radiation; CT, chemotherapy; SVC, superior vena cava; NA, not available; AWD, alive with disease; DOD, died of disease.